A 5733 (see companion bill S 2544) – New York
Introduced: 2017 Status: Inactive / Dead
PRICE GOUGING: PRESCRIPTION DRUGS. If a drug manufacturer of a brand or generic drug, made available in New York, increases the wholesale acquisition cost (WAC) of a drug by a percent equal to or greater …
A 5743 (see companion bill S 4062) – New Jersey
Introduced: 2019 Status: Inactive / Dead
Requires carriers to pass prescription drug savings to consumers.
A 5786 (see companion bill S 4350) – New Jersey
Introduced: 2019 Status: Inactive / Dead
Places $100 cap on amount paid by covered persons for purchase of insulin drugs; requires Division of Consumer Affairs to investigate insulin prices.
A 5802 – New York
Introduced: 2017 Status: Inactive / Dead
Relates to having the state reimburse all local costs for medicaid.
A 583 (see companion bill S 983) – New Jersey
Introduced: 2018 Status: Inactive / Dead
PRESCRIPTION DRUG REVIEW COMMISSION: The commission shall develop a list of critical prescription drugs made available in New Jersey for which there is a substantial public interest in understanding the development of pricing for the …
A 5850 (see companion S 4565) – New York
Introduced: 2021 Status: In Process
Relates to price gouging; defines unconscionably excessive price for the purposes of prohibiting price gouging during abnormal disruption of the market.
A 5860 – New York
Introduced: 2021 Status: In Process
Prohibits selling a drug subject to a shortage for an unconscionably excessive price.
A 5877 – New York
Introduced: 2021 Status: In Process
Provides that prescription benefit plans may not require patients to receive prescriptions through mail order pharmacies.
A 5911 (see companion bill S 5136) – New York
Introduced: 2023 Status: In Process
Relates to pharmacy services provided by managed care providers; requires pharmacy benefit managers and managed care providers to reimburse retail pharmacies for each outpatient drug, at the National Average Drug Acquisition Cost (NADAC); repeals related …
A 5914 – New Jersey
Introduced: 2021 Status: Inactive / Dead
Requires health insurance carriers to utilize real time benefit tool for prescription drugs.
A 5920 – New Jersey
Introduced: 2019 Status: Inactive / Dead
Requires rate review study of provider reimbursement rates provided by Medicaid and Children’s System of Care for pediatric and adult psychiatry services.
A 5935 (see companion bill S 3898) – New Jersey
Introduced: 2021 Status: Inactive / Dead
Removes exception of self-insured health benefits plans from law concerning pharmacy benefits managers.
A 5947 – New Jersey
Introduced: 2019 Status: Inactive / Dead
Permits import of Canadian prescription drugs.
A 5947 – New Jersey
Introduced: 2019 Status: Inactive / Dead
Permits import of Canadian prescription drugs.
A 5948 – New Jersey
Introduced: 2019 Status: Inactive / Dead
Limits amount paid by covered persons for purchase of insulin drugs and epinephrine; requires Division of Consumer Affairs to investigate insulin prices.
A 5999 – New Jersey
Introduced: 2019 Status: Inactive / Dead
Prohibits pharmacy benefits managers from requiring covered persons to use mail service pharmacies.